Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Influence of Polyvalent Mechanical Bacterial Lysate ISMIGEN® on Clinical Course of Asthma and Related Immunological Parameters in Asthmatic Children (EOLIA Study): Randomised Double-blind Placebo-controlled Multicentre Parallel-group Study

NCT02541331 is registered in ClinicalTrials.gov with Lallemand Pharma AG as lead sponsor.

NCT NCT02541331
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02541331 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Influence of Polyvalent Mechanical Bacterial Lysate ISMIGEN® on Clinical Course of Asthma and Related Immunological Parameters in Asthmatic Children (EOLIA Study): Randomised Double-blind Placebo-controlled Multicentre Parallel-group Study
Lead sponsor
Lallemand Pharma AG
Phase
Phase 3
Overall status
Completed
Start date
July 31, 2014
Completion date
June 30, 2015
Enrollment
150 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

allergic asthma